Cellcept and Brain abscess - a phase IV clinical study of FDA data

Summary:

Brain abscess is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Prograf, and have Graft versus host disease.

The phase IV clinical study analyzes which people have Brain abscess when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Brain abscess?

Brain abscess is found to be associated with 226 drugs and 624 conditions by eHealthMe. Check the latest studies of Brain abscess.

On Jul, 20, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 46 people (0.11%) have Brain abscess.

Among these 46 people:

How long have people been on Cellcept when they have Brain abscess? *

What is the gender of people who have Brain abscess when taking Cellcept? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Brain abscess when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Brain abscess? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 11 people, 23.91%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 10 people, 21.74%
Nocardia Infection (a bacterial infection that usually starts in the lungs. it may spread to other organ systems): 9 people, 19.57%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 6 people, 13.04%
Transplant Rejection (a transplant material is not worked): 6 people, 13.04%
Acute Kidney Failure: 6 people, 13.04%
Skin Abscess: 5 people, 10.87%
Opportunistic Infection (a microorganism that normally does not cause disease but becomes pathogenic when the body's immune system is impaired and unable to fight): 5 people, 10.87%
Death: 5 people, 10.87%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 5 people, 10.87%

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 17 people, 36.96%
Meningoencephalitis Herpetic (inflammation of the brain and meninges by virus): 11 people, 23.91%
Hiv Infection: 1 person, 2.17%
Focal Segmental Glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli): 1 person, 2.17%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Brain abscess?

- Check whether Brain abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Brain abscess treatments and more:

Brain abscess (3,459 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain abscess:

Brain abscess (226 drugs)

Browse all the conditions that are associated with Brain abscess:

Brain abscess (624 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.